A randomized controlled trial of Deep Brain Reorienting: a neuroscientifically guided treatment for post-traumatic stress disorder.
Breanne E Kearney, Frank M Corrigan, Paul A Frewen...
https://pubmed.ncbi.nlm.nih.gov/37581275/Actively Recruiting
Led by University of Alberta · Updated on 2026-10-05
50
Participants Needed
1
Research Sites
26 weeks
Total Duration
Researchers are evaluating Deep Brain Reorienting DBR, a psychotherapy targeting brainstem responses, to treat posttraumatic stress disorder PTSD symptoms in military veterans. The study aims to find out if DBR reduces PTSD symptoms compared with usual treatment and whether these improvements last for three months after treatment. The trial is sponsored by the University of Alberta and involves a randomized comparison between DBR and a waitlist receiving treatment as usual. Participants will be randomly assigned to one of two groups one will receive eight weekly DBR sessions guided by certified trauma clinicians, each lasting about 50 minutes, focusing on orienting tension, shock activation, and trauma integration without verbal exploration of traumatic memories. The other group will continue with their usual treatment over an eight-week waiting period and may be offered DBR afterward if eligible. Participants complete questionnaires and interviews before, during, and after treatment, including a follow-up at three months. Throughout the study, participants answer questions about their PTSD symptoms and complete short questionnaires before and after each session. Researchers measure changes in PTSD severity using standardized tools at eight weeks and three months, as well as assess dissociation, depression, trauma-related shame, interoceptive awareness, physical symptoms, and emotional regulation. Participants experiences with DBR and mental health professionals perspectives on learning DBR are also explored. The study lasts at least eight weeks plus a three-month follow-up.
CONDITIONS
Deep Brain Reorienting for Posttraumatic Stress Disorder
O
Olga Winkler (Psychiatrist and Associate Clinical Professor), MD, FRCPC
L
Lisa Burback (Psychiatrist and Associate Clinical Professor), BSc(Pharm), MD, FRCPC
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Alberta
Lead Sponsor
Western University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened to confirm eligibility for the trial, including diagnosis and suitability for therapy.
1 screening visit
Duration - 8 weeks
Participants receive either eight weekly Deep Brain Reorienting therapy sessions or continue usual treatment during an eight-week period.
Weekly therapy sessions and assessments
Duration - 3 months
Participants complete follow-up assessments to measure PTSD symptoms and other outcomes three months after treatment ends.
1 follow-up visit
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Breanne E Kearney, Frank M Corrigan, Paul A Frewen...
https://pubmed.ncbi.nlm.nih.gov/37581275/F M Corrigan, J Christie-Sands
https://pubmed.ncbi.nlm.nih.gov/31794877/Costanzo Frau, Frank M Corrigan
https://pubmed.ncbi.nlm.nih.gov/40098781/University of Alberta
Lead Sponsor
Western University
Collaborating Sponsor